Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02368691
Title Efficacy and Safety of GTx-024 in Patients With Androgen Receptor-Positive Triple Negative Breast Cancer (AR+ TNBC)
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors GTx
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.